Literature DB >> 9246796

Heroin smoking by 'chasing the dragon': origins and history.

J Strang1, P Griffiths, M Gossop.   

Abstract

The history of heroin smoking and the subsequent development and spread of 'chasing the dragon' are examined. The first heroin smoking originated in Shanghai in the 1920s and involved use of porcelain bowls and bamboo tubes, thereafter spreading across much of Eastern Asia and to the United States over the next decade. 'Chasing the dragon' was a later refinement of this form of heroin smoking, originating in or near Hong Kong in the 1950s, and refers to the ingestion of heroin by inhaling the vapours which result when the drug is heated-typically on tin-foil above a flame. Subsequent spread of 'chasing the dragon' included spread to other parts of South East Asia during the 1960s and 1970s, to some parts of Europe during the late 1970s and early 1980s, and to much of the Indian sub-continent during the 1980s. At the time of writing, 'chasing the dragon' has now been reliably reported from many parts of the world but not from others with an established heroin problem-such as the United States and Australia. The significance of this new form of heroin use is examined, including consideration of the role of the different effect with this new form of use, the different types of heroin, and changing public attitudes to injecting.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246796     DOI: 10.1046/j.1360-0443.1997.9266734.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  15 in total

Review 1.  Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.

Authors:  Kurt F Hauser; Valeriya K Khurdayan; Robin J Goody; Avindra Nath; Alois Saria; James R Pauly
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

2.  Valsalva manoeuvre effect on distribution of lung damage in heroin inhalation.

Authors:  S J Prowse; T Lima; K L Irion; H Burhan; B Hochhegger; E Marchiori
Journal:  Br J Radiol       Date:  2011-10       Impact factor: 3.039

3.  Toxic leukoencephalopathy after intravenous heroin injection: a case with clinical and radiological reversibility.

Authors:  Corrado Villella; Raffaele Iorio; Gianluigi Conte; Anna Paola Batocchi; Pietro Bria
Journal:  J Neurol       Date:  2010-06-18       Impact factor: 4.849

4.  Un Jalón, Un Volteón, y Otra Vez: High-Risk Crack Smoking Paraphernalia in México City.

Authors:  Avelardo Valdez; Kathryn M Nowotny; Nalini Negi; Eduardo Zafra Mora; Alice Cepeda
Journal:  J Psychoactive Drugs       Date:  2016-06-29

5.  Non-cardiogenic pulmonary edema, rhabdomyolysis and myocardial injury following heroin inhalation: a case report.

Authors:  G Bazoukis; A Spiliopoulou; K Mourouzis; P Grigoropoulou; A Yalouris
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

6.  Female rats self-administer heroin by vapor inhalation.

Authors:  Arnold Gutierrez; Jacques D Nguyen; Kevin M Creehan; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2020-10-24       Impact factor: 3.533

Review 7.  Stimulant methamphetamine and dextromethorphan use among Thai adolescents: implications for health of women and children.

Authors:  Chulathida Chomchai; Boonying Manaboriboon
Journal:  J Med Toxicol       Date:  2012-09

8.  Population pharmacokinetics of heroin and its major metabolites.

Authors:  Elisabeth J Rook; Alwin D R Huitema; Wim van den Brink; Jan M van Ree; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

9.  Strategies to avoid opiate withdrawal: implications for HCV and HIV risks.

Authors:  Pedro Mateu-Gelabert; Milagros Sandoval; Peter Meylakhs; Travis Wendel; Samuel R Friedman
Journal:  Int J Drug Policy       Date:  2009-09-27

10.  Eosinophilic pneumonia associated with heroin inhalation: a case report.

Authors:  Apostolos Tsapas; Konstantinos Paletas; Efthymia Vlachaki; Eleni Bekiari; Constantine Spanos; Dimitrios Economidis
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.